Neurocrine Biosciences Inc (NBIX)
Payables turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 1,044,800 | 930,800 | 776,400 | 583,300 | 433,300 |
| Payables | US$ in thousands | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue ÷ Payables
= $1,044,800K ÷ $—K
= —
The payables turnover ratio measures how efficiently a company is managing its accounts payable. In this case, the data provided indicates that Neurocrine Biosciences Inc has not disclosed any specific figures for its payables turnover for the years 2020 through 2024. The absence of data on payables turnover limits our ability to assess the company's efficiency in managing its supplier payments and how quickly it pays off its accounts payable.
It is important for investors and analysts to closely monitor the payables turnover ratio to understand the company's payment practices and relationship with its suppliers. Since the specific figures are not available in this case, further insights into Neurocrine Biosciences Inc's payables turnover management cannot be provided at this time.
Peer comparison
Dec 31, 2024